Extended and sequential delivery of protein from injectable thermoresponsive hydrogels

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 3, 2012, Pages 776-785

  Nelson, Devin M ^a,b   Ma, Zuwei ^b   Leeson, Cory E ^a   Wagner, William R ^a,b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

hydrogel; injectable; NIPAAm; sequential protein delivery; thermoresponsive

Indexed keywords

2-HYDROXYETHYL METHACRYLATE; ACRYLIC ACIDS; BIODEGRADABLE HYDROGELS; BIODEGRADABLE MICROPARTICLES; BOVINE SERUM ALBUMINS; DEGRADABILITY; DRUG DELIVERY SYSTEM; EXTENDED RELEASE; IN-VITRO; INJECTABILITY; INJECTABLE; MECHANICAL SUPPORT; MICRO-PARTICLES; N-HYDROXYSUCCINIMIDE; N-ISOPROPYLACRYLAMIDES; NIPAAM; POLY LACTIDE; POLY LACTIDE-CO-GLYCOLIDE; PROTEIN RELEASE; PROTEIN RETENTION; SEQUENTIAL DELIVERY; SEQUENTIAL PROTEIN DELIVERY; THERMAL TRANSITIONS; THERMO-RESPONSIVE; THERMORESPONSIVE HYDROGELS; TISSUE ENGINEERING APPLICATIONS; TISSUE REMODELING;

ACRYLIC MONOMERS; AMIDES; BIOMATERIALS; BIOSYNTHESIS; BODY FLUIDS; CARBOXYLIC ACIDS; COPOLYMERS; DRUG DELIVERY; MICROSPHERES; PROTEINS; SCAFFOLDS (BIOLOGY); TISSUE;

HYDROGELS;

2 HYDROXYETHYL METHACRYLATE; ACRYLIC ACID; BOVINE SERUM ALBUMIN; METHACRYLATE POLYLACTIDE; METHACRYLOXY N HYDROXYSUCCINIMIDE; MICROSPHERE; POLY(N ISOPROPYLACRYLAMIDE); POLYMER; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABLE IMPLANT; BODY SURFACE; DRUG DELIVERY SYSTEM; HEAT SENSITIVITY; HYDROGEL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STABILITY;

ACRYLAMIDES; ACRYLATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGELS; INJECTIONS; MATERIALS TESTING; METHACRYLATES; MICROSPHERES; MOLECULAR STRUCTURE; POLYESTERS; POLYMERS; SERUM ALBUMIN, BOVINE; TEMPERATURE;

EID: 84856219146     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34015     Document Type: Article

References (50)

1. Gutowska A, Jeong B, Jasionowski M,. Injectable gels for tissue engineering. Anat Rec 2001; 263: 342-349. (Pubitemid 32730261)
2. Kretlow JD, Klouda L, Mikos AG,. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 263-273. (Pubitemid 46879970)
3. Yu L, Ding J,. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008; 37: 1473-1481.
4. Stile RA, Burghardt WR, Healy KE,. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999; 32: 7370-7379. (Pubitemid 30537680)
5. Guan J, Hong Y, Ma Z, Wagner WR,. Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability. Biomacromolecules 2008; 9: 1283-1292. (Pubitemid 351639583)
6. Kim S, Healy KE,. Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003; 4: 1214-1223. (Pubitemid 37184633)
7. Lee BH, Vernon BL,. In situ-gelling, erodible N-isopropylacrylamide copolymers. Macromol Biosci 2005; 5: 629-635. (Pubitemid 41020254)
8. Ma Z, Nelson DM, Hong Y, Wagner WR,. Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules 2010; 11: 1873-1881.
9. Lee BH, West B, McLemore R, Pauken C, Vernon BL,. In-situ injectable physically and chemically gelling NIPAAm-based copolymer system for embolization. Biomacromolecules 2006; 7: 2059-2064. (Pubitemid 43985133)
10. Stile RA, Healy KE,. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules 2001; 2: 185-194. (Pubitemid 32707490)
11. Cui Z, Lee BH, Pauken C, Vernon BL,. Manipulating degradation time in a N-isopropylacrylamide-based co-polymer with hydrolysis-dependent LCST. J Biomater Sci Polym Ed 2010; 21: 913-926.
12. Overstreet DJ, Dhruv HD, Vernon BL,. Bioresponsive copolymers of poly(N-isopropylacrylamide) with enzyme-dependent lower critical solution temperatures. Biomacromolecules 2010; 11: 1154-1159.
13. Chen JP, Cheng TH,. Thermo-responsive chitosan-graft-poly(N- isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. Macromol Biosci 2006; 6: 1026-1039.
14. Fujimoto KL, Ma Z, Nelson DM, Hashizume R, Guan J, Tobita K, Wagner WR,. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009; 30: 4357-4368.
15. Vernengo J, Fussell GW, Smith NG, Lowman AM,. Evaluation of novel injectable hydrogels for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater 2008; 84B: 64-69.
16. Wang F, Li Z, Khan M, Tamama K, Kuppusamy P, Wagner WR, Sen CK, Guan J,. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater 2010; 6: 1978-1991.
17. Ibusuki S, Fujii Y, Iwamoto Y, Matsuda T,. Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng 2003; 9: 371-384. (Pubitemid 36944187)
18. Babensee JE, McIntire LV, Mikos AG,. Growth factor delivery for tissue engineering. Pharm Res 2000; 17: 497-504. (Pubitemid 30416385)
19. Richardson TP, Peters MC, Ennett AB, Mooney DJ,. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-1034. (Pubitemid 33041886)
20. Sinha VR, Trehan A,. Biodegradable microspheres for protein delivery. J Control Release 2003; 90: 261-280. (Pubitemid 36859959)
21. Hoare TR, Kohane DS,. Hydrogels in drug delivery: Progress and challenges. Polymer 2008; 49: 1993-2007.
22. Holland TA, Tabata Y, Mikos AG,. In vitro release of transforming growth factor-[beta]1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 2003; 91: 299-313. (Pubitemid 36976762)
23. Patel Z, Ueda H, Yamamoto M, Tabata Y, Mikos A,. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 2008; 25: 2370-2378.
24. DeFail AJ, Chu CR, Izzo N, Marra KG,. Controlled release of bioactive TGF-[beta]1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006; 27: 1579-1585. (Pubitemid 41739583)
25. Lee J, Tan CY, Lee S-K, Kim Y-H, Lee KY,. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release 2009; 137: 196-202.
26. Park M-R, Chun C, Ahn S-W, Ki M-H, Cho C-S, Song S-C,. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel. J Control Release 2010; 147: 359-367.
27. Holland TA, Tabata Y, Mikos AG,. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005; 101: 111-125. (Pubitemid 39600976)
28. Holland TA, Bodde EWH, Cuijpers VMJI, Baggett LS, Tabata Y, Mikos AG, Jansen JA,. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 2007; 15: 187-197. (Pubitemid 46132102)
29. Peattie RA, Rieke ER, Hewett EM, Fisher RJ, Shu XZ, Prestwich GD,. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials 2006; 27: 1868-1875. (Pubitemid 41759481)
30. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ,. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004; 35: 562-569. (Pubitemid 38953205)
31. Hao X, Silva EA, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Wardell E, Brodin LA, Mooney DJ, Sylven C,. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007; 75: 178-185. (Pubitemid 46876668)
32. Buket Basmanav F, Kose GT, Hasirci V,. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008; 29: 4195-4204.
33. Tengood JE, Kovach KM, Vescovi PE, Russell AJ, Little SR,. Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials 2010; 31: 7805-7812.
34. Kim BS, Oh JM, Kim KS, Seo KS, Cho JS, Khang G, Lee HB, Park K, Kim MS,. BSA-FITC-loaded microcapsules for in vivo delivery. Biomaterials 2009; 30: 902-909.
35. Ahmed B, Kamal MZ, Khan RH,. Alkali-induced conformational transition in different domains of bovine serum albumin. Protein Pept Lett 2004; 11: 307-315. (Pubitemid 38908576)
36. Nelson DM, Ma Z, Fujimoto KL, Hashizume R, Wagner WR,. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater 2011; 7: 1-15.
37. Zachary I, Morgan R,. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2010; 97: 181-189.
38. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M,. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999; 100: 1865-1871. (Pubitemid 29511139)
39. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, Tabata Y,. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 2003; 18: 93-99. (Pubitemid 36701553)
40. Shao ZQ, Takaji K, Katayama Y, Kunitomo R, Sakaguchi H, Lai ZF, Kawasuji M,. Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ J 2006; 70: 471-477.
41. Crotts G, Park TG,. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Release 1995; 35: 91-105.
42. Yang Y-Y, Chia H-H, Chung T-S,. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Control Release 2000; 69: 81-96.
43. Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T,. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007; 334: 137-148. (Pubitemid 46400322)
44. Ruvinov E, Leor J, Cohen S,. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011; 32: 565-578.
45. Lin CC, Metters AT,. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev 2006; 58: 1379-1408.
46. Brazel CS, Peppas NA,. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. J Control Release 1996; 39: 57-64. (Pubitemid 26139811)
47. Huang X, Lowe TL,. Biodegradable thermoresponsive hydrogels for aqueous encapsulation and controlled release of hydrophilic model drugs. Biomacromolecules 2005; 6: 2131-2139. (Pubitemid 41052209)
48. Ye M, Kim S, Park K,. Issues in long-term protein delivery using biodegradable microparticles. J Control Release 2010; 146: 241-260.
49. Harris JM, Chess RB,. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003; 2: 214-221. (Pubitemid 37361666)
50. Roberts MJ, Bentley MD, Harris JM,. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002; 54: 459-476. (Pubitemid 34615543)